Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
17. Juli 2023 16:05 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed...
The clinical trial planning and design services market is projected to grow at 8% CAGR by 2030, claims Roots Analysis
15. Dezember 2021 08:00 ET
|
Roots Analysis
London, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Clinical Trial Planning and Clinical Trial Design Services Market, 2021-2030” report to its list of offerings....